[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.112.177. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 1992

Intravitreal Aminoglycoside Toxicity Revisited-Reply

Author Affiliations

New Orleans, La

Arch Ophthalmol. 1992;110(12):1684. doi:10.1001/archopht.1992.01080240021010

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

In Reply.  —We appreciate the interest and concern of Dr Pulido et al regarding the determination of aminoglycoside toxicity following intravitreal administration. Basic toxicity studies are performed for safety assessment so we can predict the likely adverse effects of a drug in humans. Two objectives of toxicity studies include defining a nontoxic (no observable effect) dose level and a toxic dose level. The characterization of the dose-response relationship for toxic effects observed at doses above the no-effect level is vital. Two approaches can be undertaken to achieve the objectives: incremental increases in the drug-dose level, and a log-dose interval, as suggested by Dr Pulido et al.An experimental data set with a dose-response relationship over several log units of drug dose may allow reliable interpretation of the results and perhaps extrapolation of the results to humans, as stated by Dr Pulido et al. The log doseresponse relationship is critically important

First Page Preview View Large
First page PDF preview
First page PDF preview
×